RS 09(Cat No.:P000319)is a synthetic lipopeptide and potent agonist of Toll-like receptor 4 (TLR4), developed as a safer and more effective alternative to bacterial lipopolysaccharide (LPS) for immune stimulation. By activating TLR4 signaling, it triggers innate immune responses, including NF-κB activation, cytokine release, and dendritic cell maturation, thereby enhancing adaptive immunity. RS 09 is widely used in immunology and vaccine research to study TLR4-mediated pathways, host–pathogen interactions, and adjuvant development. Its well-defined structure and reduced toxicity make it a reliable tool for probing innate immune activation mechanisms.